Health and Fitness Health and Fitness
Mon, November 1, 2010
[ Mon, Nov 01st 2010 ] - Market Wire
Orthovita to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
[ Mon, Nov 01st 2010 ] - Market Wire
Theragenics to Report Third Quarter 2010 Financial Results Tuesday, November 9
[ Mon, Nov 01st 2010 ] - Market Wire
I composti sperimentali per l'epatite C di Gilead .. azione con terapie standard di cura ottengono una
[ Mon, Nov 01st 2010 ] - Market Wire
Two Directors Step Down from Elan Board in Accordance with Previously Announced Intention
[ Mon, Nov 01st 2010 ] - Market Wire
Health Management Associates, Inc. to Present at the Oppenheimer 21st Annual Healthcare Conference
[ Mon, Nov 01st 2010 ] - Market Wire
Porex Corporation Divests Surgical Division to Stryker Corporation
[ Mon, Nov 01st 2010 ] - Market Wire
Medisafe 1 Technologies Appoints Tali Skoczylas as Chair of Medical Advisory Board
Sat, October 30, 2010
[ Sat, Oct 30th 2010 ] - Market Wire
A Celgene anuncia resultados financeiros e operacionais recordes no terceiro trimestre de 2010
[ Sat, Oct 30th 2010 ] - Market Wire
Viread® for Hepatitis B Maintains Antiviral Supp .. ent of Resistance Through Four Years of Treatment
[ Sat, Oct 30th 2010 ] - Market Wire
New Data From Phase 3 Studies Showed Superior SVR .. with Telaprevir-Based Combination Therapy in Peop
[ Sat, Oct 30th 2010 ] - Market Wire
Salix Pharmaceuticals Previews Data Slated for Pr .. ting of the American Association for the Study of
[ Sat, Oct 30th 2010 ] - Market Wire
Gileada?s Investigational Hepatitis C Compounds G .. tion with Standard of Care Therapies Achieve Subs
Fri, October 29, 2010
[ Fri, Oct 29th 2010 ] - Market Wire
Angiotech Pharmaceuticals, Inc. Announces a Stron .. eement with Majority of Senior Subordinated Noteh
[ Fri, Oct 29th 2010 ] - Market Wire
Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information
[ Fri, Oct 29th 2010 ] - Market Wire
Forest Announces FDA Approval of Teflaroa" (cefta .. ment of Community-Acquired Bacterial Pneumonia an
[ Fri, Oct 29th 2010 ] - Market Wire
FDA Classifies Previous Field Action of Medtronic Surgical Device as Class I Recall
[ Fri, Oct 29th 2010 ] - Market Wire
Inhibitex to Present at Two Upcoming Investor Conferences
[ Fri, Oct 29th 2010 ] - Market Wire
ArthroCare Announces Third Quarter 2010 Financial Results Press Release and Conference Call Dates
[ Fri, Oct 29th 2010 ] - Market Wire
Wright Medical Group, Inc. to Participate in the 2010 Annual Credit Suisse Healthcare Conference
[ Fri, Oct 29th 2010 ] - Market Wire
Inhibitex to Host Conference Call to Report Third Quarter Financial Results on November 9, 2010
[ Fri, Oct 29th 2010 ] - Market Wire
Fitch Affirms Boston Scientific's IDR at 'BB+'; Outlook to Positive
[ Fri, Oct 29th 2010 ] - Market Wire
Ligand to Report Third Quarter Results on November 9
[ Fri, Oct 29th 2010 ] - Market Wire
Teva Invites Public to Listen to Its Respiratory Opportunity Meeting Webcast
[ Fri, Oct 29th 2010 ] - Market Wire
Amedisys to Present at Three Upcoming Conferences
[ Fri, Oct 29th 2010 ] - Market Wire
Kendall Law Group Investigates BMP Sunstone Corporation Acquisition for Shareholders
[ Fri, Oct 29th 2010 ] - Market Wire
St. Jude Medical???2010??????????????
[ Fri, Oct 29th 2010 ] - Market Wire
CORRECTING and REPLACING Abstracts Highlighting D .. nist Programs Accepted for Presentation at 2010 E
[ Fri, Oct 29th 2010 ] - Market Wire
Celgene meldet rekordverdchtiges Betriebs- und Finanzergebnis fr das dritte Quartal 2010
[ Fri, Oct 29th 2010 ] - Market Wire
Zynex Ranked 8th in Growth Among Medical Equipment Companies.
[ Fri, Oct 29th 2010 ] - Market Wire
China Kanghui Holdings to Report Third Quarter 2010 Financial Results

China Kanghui Holdings to Report Third Quarter 2010 Financial Results


Published on 2010-10-29 06:35:56 - Market Wire
  Print publication without navigation


CHANGZHOU, China--([ BUSINESS WIRE ])--China Kanghui Holdings (NYSE: KH) (aKanghuia or the aCompanya), a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced that the Company plans to release third quarter 2010 financial results on Monday, November 8, 2010, before the market opens.

The Company will hold a conference call at 8:30 am ET on November 8, 2010 to discuss third quarter results. Listeners may access the call by dialing:

United States toll free: 1-866-510-0707
China toll free: 10-800-712-2655
China toll: 400-881-1629
Hong Kong toll free: 800-963-844
International: 1-617-597-5376
Conference ID: 70059571

A telephone replay will be accessible through November 15, 2010 by dialing:

United States toll free: 1-888-286-8010
International: 1-617-801-6888
Conference ID: 10763709

A webcast will also be available through the Companya™s website at [ www.kanghui.com ].

About China Kanghui Holdings

Founded in 1997, Kanghui is a leading domestic developer, manufacturer and marketer of orthopedic implants in China. The Company offers a wide array of proprietary orthopedic implant products in trauma and spine. It has an extensive network of distributors for its products in China. In addition, Kanghuia™s products are distributed in 24 countries. Kanghui has strong research and development capabilities, focused on developing new proprietary products, including new product lines, extensions of existing product lines and enhancements of existing products. For more information, please visit [ www.kanghui.com ].

Contributing Sources